Tal y como hemos realizado con congresos previos, a lo largo de la celebración del Congreso Europeo de Cardiología (Munich, 25 a 29 de Agosto) comentaremos en el blog los principales resultados de los ensayos clínicos más importantes.
Nos centraremos en los siguientes:
Hot Line I – Prevención de Insuficiencia Cardiaca
26 de Agosto, 11:00 – 12:30
PURE: Patterns of risk factor prevalence for CVD globally by urbanization, gender, and economic status of countries and individuals: The Prospective Urban Rural Epidemiologic (PURE) Study of 153,996 people from 628 communities in 17 countries. Salim YUSUF (Hamilton, CA)
DeFACTO: Determination of Fractional Flow Reserve by Anatomic Computed Tomographic Angiography. James MIN (Los Angeles, US)
ALTITUDE: ALiskiren Trial In Type 2 Diabetes Using cardio-renal Endpoints. Hans Henrik PARVING (Copenhagen, DK)
TRILOGY-ACS: Prasugrel versus clopidodrel for patients with Unstable Angina/NSTEMI who are medically managed without revascularization. Matthew ROE (Durham, US)
PARAMOUNT: Efficacy and Safety of LCZ696, a First-in-Class Angiotensin Receptor Neprilysin Inhibitor, in Patients with Heart Failure and Preserved Ejection Fraction: Primary Results from the PARAMOUNT Study. Scott SOLOMON (Boston, US)
Aldo-DHF: Aldosterone Receptor Blockade in Diastolic Heart Failure. Burkert Mathias PIESKE (Graz, AT)
Hot Line II – Intervenciones
27 de Agosto, 11:00 – 12:30
IABP-SHOCK II: Randomized comparison of intraaortic balloon counterpulsation versus optimal medical therapy in addition to early revascularization in acute myocardial infarction complicated by cardiogenic shock.. Holger THIELE (Leipzig, DE)
PROTECT: Primary Results from PROTECT: thePatient Related Outcomes with Endeavor versus Cypher Stenting Trial. William WIJNS (Aalst, BE)
GARY: German Aortic Valve RegistrY – in hospital outcome. Christian HAMM (Bad Nauheim, DE)
ACCESS-EUROPE – An Observational Study of the MitraClip® System in Europe. Wolfgang SCHILLINGER (Gottingen, DE)
FAST-MI programme: Decrease in early mortality in STEMI is related to changing patient profile and behavior, as well as improved organization of care: Data from 4 French nationwide surveys over 15 years. Nicolas DANCHIN (Paris, FR)
GRACE: Effects of Insulin Glargin and of Polyunsaturated Fatty Acids on Carotid Intima Media Thickness in High-Risk Diabetes. Eva LONN (Hamilton, CA. USA)
Hot Line III – Arritmias y enfermedad coronaria
28 de Agosto, 11:00 – 12:30
PRAGUE-12: Randomized open multicenter study comparing cardiac surgery with MAZE versus cardiac surgery without MAZE in patients with coronary and/or valvular heart disease and with atrial fibrillation. Petr WIDIMSKY (Prague, CZ)
WOEST: First randomised trial that compares two different regimens with and without aspirin in patients on oral anticoagulant therapy (OAC) undergoing coronary stent placement (PCI). Willem DEWILDE (Nieuwegein, NL)
AFib Ablation Pilot: ESC-EURObservational Research Programme: 1-year follow-up of the Atrial Fibrillation Ablation Conducted by the European Heart Rhythm Association. Elena ARBELO (Las Palmas de Gran Canaria, ES)
The Great East Japan Earthquake Disaster and Cardiovascular Diseases. Hiroaki SHIMOKAWA (Sendai, JP)
CORE320: Diagnostic Performance of Combined Noninvasive Coronary Angiography and Myocardial Perfusion Imaging Using 320-row Detector Computed Tomography: The CORE320 Multicenter, Multinational Study. Joao Ac LIMA (Baltimore, US)
FAME II: Fractional Flow Reserve-Guided Percutaneous Coronary Intervention plus Optimal Medical Treatment versus Optimal Medical Treatment Alone in Patients with Stable Coronary Artery Disease. Bernard DE BRUYNE (Aalst, BE)